Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2118 studies found for:    TNF
Show Display Options
Rank Status Study
1 Completed Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
Condition: Spondylarthropathies
Interventions: Drug: Reduced doses of anti-TNF;   Drug: Stable doses of anti-TNF
2 Completed Intratumoral Administration of L19IL2/L19TNF
Condition: Malignant Melanoma, Skin
Intervention: Drug: L19IL2+L19TNF
3 Completed Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population
Condition: Ankylosing Spondylitis
Interventions: Drug: anti TNF alpha agent;   Drug: Anti TNF alpha therapy
4 Completed Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: Withdrawal of anti-TNF therapy
5 Recruiting Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: TNF Antagonist (enbrel, humire, remicade, cimzia, symponi);   Drug: Abatacept;   Drug: Tocilizumab
6 Recruiting 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
Conditions: Psoriatic Arthritis;   Arthritis
Intervention: Other: 99mTc-anti-TNF-alpha Scintigraphy
7 Unknown  Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
Conditions: Arthritis, Rheumatoid;   Spondylitis, Ankylosing
Intervention: Drug: TNF blockers (infliximab, adalimumab, etanercept)
8 Recruiting Anti TNF α Improves Endothelial Dysfunction in IBD Patients
Condition: Crohn's Disease
Interventions: Device: Endopath from Itamar medical - FDA approved device.;   Drug: Anti TNF Alfa.
9 Completed 23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: anti-TNF
10 Not yet recruiting Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection
Condition: Quality of Life
Interventions: Drug: Anti TNF;   Procedure: ileocecal resection
11 Recruiting A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.
Condition: Rheumatoid Arthritis
Intervention: Drug: TNF inhibitor/TCZ
12 Unknown  Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
13 Completed A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube
Condition: Inflammatory Rheumatic Diseases
Intervention: Biological: QuantiFERON-TB Gold In-Tube (QFT-GIT)
14 Completed Lumbar Spinal Fibrosis and TNF Alpha Inhibition
Condition: Post Operative Sciatica by Lumbar Spinal Fibrosis
Interventions: Drug: TNF blocker;   Drug: Placebo
15 Recruiting RHYTHM (Formerly Escape II Myocardium)
Condition: Rheumatoid Arthritis
Intervention: Drug: TNF inhibitors
16 Completed Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
Conditions: Crohn's Disease;   Ulcerative Colitis;   Inflammatory Bowel Disease
Intervention: Biological: infliximab and adalimumab
17 Recruiting Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
Condition: Rheumatoid Arthritis
Intervention:
18 Completed Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: TNF-Kinoid
19 Terminated Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
Condition: Rheumatoid Arthritis
Intervention:
20 Recruiting Biomarkers of Anti-TNF Treatment in IBD
Condition: Inflammatory Bowel Diseases
Interventions: Biological: Infliximab;   Biological: Adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.